Background. Episignatures, disorder-specific patterns of genome-wide DNA methylation, are established for more than 100 Mendelian conditions and help resolve variants of uncertain significance and evaluate unsolved cases. Current clinical testing approaches typically use data generated by methylation arrays, which require a specific assay and limit discovery to the probe set of the array.
EpiSignaLR: an open resource for genome-wide episignature analysis from methylation-aware short- and long-read sequencing
calendar_today
October 23, 2026
person
Gibson, S. B., Zalusky, M. P. G., Goffena, J., Hamlin, E. J., Lamb, R., Rosinski, J. R., Prall, T., Anderson, Z. B., Storz, S. H. R., Miller, A. L., Shi, Y., Lanko, K., Mulder, D., Shen, Y., Lensing, K., Elferink, M. G., Vergano, S., Wojcik, M. H., van Gassen, K. L. I., Gibson, W. T., Jones, S. J. M., Barakat, T. S., Miller, D. E.
domain
medrxiv